Developer docs
API playgroundTry for free, no card

Search company profiles

Bioskin

Full company profile

uuid000lj6m

Namestring
Bioskin
Legal namestring
Bioskin GmbH
Websiteurl
bioskincro.com
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Eurofins bioskin (Bioskin GmbH) is a full-service Contract Research Organization (CRO) specialized exclusively in dermatology and aesthetics, founded in 1992 and headquartered in Hamburg, Germany. The company plans and conducts clinical trials for pharmaceutical, cosmetics, and personal care companies developing dermatological products, with service coverage spanning regulatory consulting, early-phase human safety studies, Proof-of-Concept efficacy testing, vasoconstrictor assays, biophysical measurement methods, and global Phase II-IV multicenter multinational trials for new chemical entities, new formulations with known actives, and generics. It also operates a dedicated Research Center Dermatology, clinical project management, monitoring and medical monitoring, data operations (data management and statistics), quality management, and medical writing under ISO 14155:2020 certified operations.

Underlying capabilities are methodological rather than platform-tech: Bioskin's differentiation rests on specialized dermatology-tailored experimental techniques (vasoconstrictor assays, biophysical skin-property measurement, human safety readouts) integrated with regulatory consulting for dermatology-specific submission pathways. Service delivery is anchored in a Hamburg research center combined with international partnering arrangements for cross-border trial execution, with the company operating as a wholly-owned subsidiary of Eurofins Scientific SE (Euronext Paris: ERF). Headcount is reported at 51-100 employees.

The business model is B2B professional services revenue, with quote-based, project-specific pricing across four main streams: clinical development services (Phase II-IV trials), regulatory consulting, dedicated research center capacity, and data operations/medical writing. Customer segmentation is vertical: pharmaceutical companies (NCEs, reformulations, generics) form one primary segment, and cosmetics/personal care companies requiring dermatological safety and efficacy validation form the second. Go-to-market is sales-led through direct engagement with sponsor R&D teams, supported by Eurofins' corporate marketing channels and professional networks; customers are not publicly disclosed and the company has no consumer-facing distribution, app, public API, or SDK.

Short descriptiontext

Eurofins bioskin (Bioskin GmbH) is a Hamburg-based, full-service dermatology-specialized CRO conducting Phase II-IV trials, regulatory consulting, early-phase safety and Proof-of-Concept studies, and biophysical efficacy testing for pharmaceutical, cosmetics, and personal care sponsors globally as a wholly-owned subsidiary of Eurofins Scientific SE.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermatology clinical trials, clinical research organization, regulatory consulting dermatology, pharmaceutical trial services, cosmetics clinical testing
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Misc Health & Allied Services, Nec8090
Product category
Contract Research Organization (Dermatology Clinical Trials)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Development Services
TypeProfessional Services
Description

Fees for conducting Phase II-IV clinical trials for dermatological products including NCEs, new formulations with known actives, and generics. Services include safety testing, efficacy testing/Proof-of-Concept, multicenter multinational trials.

eurofins.de
2Regulatory Consulting
TypeProfessional Services
Description

Strategic and regulatory consulting services for dermatology and related products

eurofins.de
3Research Center Dermatology Services
TypeProfessional Services
Description

Specialized dermatology research center providing clinical study capabilities and infrastructure

eurofins.de
4Data Operations and Medical Writing
TypeProfessional Services
Description

Data management, statistics, and medical writing services supporting clinical trials

eurofins.de
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Eurofins bioskin is a full-service Contract Research Organization (CRO) specialized in dermatology, providing strategic and regulatory consulting, early-phase human safety and Proof-of-Concept studies, vasoconstrictor assays, and global Phase II-IV multicenter multinational trials for new chemical entities, new formulations with known actives, generics, and aesthetic dermatology products. Services are delivered for pharmaceutical companies, cosmetics, and personal care companies developing dermatological products, supported by a dedicated dermatology research center, clinical project management, monitoring, medical monitoring, data operations, quality management, and medical writing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Eurofins bioskin is a full-service CRO (Contract Research Organization) specialized in dermatology offering an integrated portfolio of services. The company provides strategic and regulatory consulting for dermatology and related products, early phase human safety and Proof-of-Concept studies, vasoconstrictor assays, and global Phase II-IV trials for NCEs, new formulations with known actives, and generics. The service portfolio spans Clinical Development (including Safety, Efficacy Testing, Multicenter Multinational Trials, Generics, International Partnering, Aesthetics, and Biophysical Measurement Methods), Research Center Dermatology, Clinical Project Management, Monitoring, Medical Monitoring, Data Operations (Data Management and Statistics), Quality Management, and Medical Writing. The services are designed to work together as an integrated offering for pharmaceutical and cosmetics companies conducting dermatology clinical trials.

Product and service10 records
1Dermatologic Consulting and Regulatory
CategoryRegulatory and Strategic Consulting
2Clinical Development
CategoryClinical Development Services
3Research Center Dermatology
CategoryClinical Research Infrastructure
4Clinical Project Management
CategoryClinical Operations
5Monitoring
CategoryClinical Operations
6Medical Monitoring
CategoryClinical Operations
7Data Operations
CategoryData and Biostatistics
8Quality Management
CategoryQuality and Compliance
9Medical Writing
CategoryMedical Writing and Regulatory Documentation
10Vasoconstrictor Assays
CategorySpecialized Dermatology Assay
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bioskin operates as a subsidiary of Eurofins Group, a global leader in bioanalytics testing. This affiliation provides access to Eurofins' broader laboratory infrastructure, regulatory expertise, and international network while maintaining specialized focus on dermatological clinical research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biorasi is a dermatology-focused CRO running clinical programs for skin and aesthetic indications. Like Bioskin it competes for the same niche sponsors seeking therapeutic-area depth over scale.

TypeDirect peer
Description

Proinnovera is a German-based dermatology CRO offering clinical trial services for skin and aesthetic products. Geographically and therapeutically, it is one of Bioskin's closest competitors in Europe.

TypeDirect peer
Description

Novum is a US-based dermatology-specialized CRO with a similar Phase II–IV service profile. It competes head-to-head with Bioskin for North American and global dermatology sponsors.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with a broad dermatology practice. It competes with Bioskin on Phase III dermatology programs and uses its scale to bid down specialty CROs.

TypeBroad incumbent
Description

Parexel is a top-5 global CRO with active dermatology and aesthetics business. It is a frequent alternative when sponsors consolidate work with large generalist providers.

TypeBroad incumbent
Description

ICON is a major global CRO with therapeutic-area breadth including dermatology. It competes for the same Phase II–IV dermatology RFPs as Bioskin, especially in larger pivotal programs.

TypeBroad incumbent
Description

Medpace is a mid-to-large global CRO with growing dermatology exposure. Its full-service model and therapeutic-area teams compete with Bioskin for sponsor mindshare in dermatology.

TypeBroad incumbent
Description

Syneos Health is a global biopharma solutions organization offering CRO services including dermatology. It is a competitor for integrated clinical development work in skin indications.

TypeBroad incumbent
Description

Charles River is a global CRO/CDMO with a sizable clinical services business that touches dermatology sponsors. It competes on the broader Phase II–IV dermatology RFP set.

10TFS International
TypeEmerging player
Description

TFS International is a mid-sized global CRO with growing dermatology and aesthetics work. It is a comparable-sized specialist expanding into the same niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioskin

Contract Research Organization (Dermatology Clinical Trials)bioskincro.com

Eurofins bioskin (Bioskin GmbH) is a Hamburg-based, full-service dermatology-specialized CRO conducting Phase II-IV trials, regulatory consulting, early-phase safety and Proof-of-Concept studies, and biophysical efficacy testing for pharmaceutical, cosmetics, and personal care sponsors globally as a wholly-owned subsidiary of Eurofins Scientific SE.

What Bioskin does

Eurofins bioskin (Bioskin GmbH) is a full-service Contract Research Organization (CRO) specialized exclusively in dermatology and aesthetics, founded in 1992 and headquartered in Hamburg, Germany. The company plans and conducts clinical trials for pharmaceutical, cosmetics, and personal care companies developing dermatological products, with service coverage spanning regulatory consulting, early-phase human safety studies, Proof-of-Concept efficacy testing, vasoconstrictor assays, biophysical measurement methods, and global Phase II-IV multicenter multinational trials for new chemical entities, new formulations with known actives, and generics. It also operates a dedicated Research Center Dermatology, clinical project management, monitoring and medical monitoring, data operations (data management and statistics), quality management, and medical writing under ISO 14155:2020 certified operations.

Underlying capabilities are methodological rather than platform-tech: Bioskin's differentiation rests on specialized dermatology-tailored experimental techniques (vasoconstrictor assays, biophysical skin-property measurement, human safety readouts) integrated with regulatory consulting for dermatology-specific submission pathways. Service delivery is anchored in a Hamburg research center combined with international partnering arrangements for cross-border trial execution, with the company operating as a wholly-owned subsidiary of Eurofins Scientific SE (Euronext Paris: ERF). Headcount is reported at 51-100 employees.

The business model is B2B professional services revenue, with quote-based, project-specific pricing across four main streams: clinical development services (Phase II-IV trials), regulatory consulting, dedicated research center capacity, and data operations/medical writing. Customer segmentation is vertical: pharmaceutical companies (NCEs, reformulations, generics) form one primary segment, and cosmetics/personal care companies requiring dermatological safety and efficacy validation form the second. Go-to-market is sales-led through direct engagement with sponsor R&D teams, supported by Eurofins' corporate marketing channels and professional networks; customers are not publicly disclosed and the company has no consumer-facing distribution, app, public API, or SDK.

Bioskin firmographics

Firmographics
Name
Bioskin
Legal name
Bioskin GmbH
Website
https://bioskincro.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
51–100 employees
Short description
Eurofins bioskin (Bioskin GmbH) is a Hamburg-based, full-service dermatology-specialized CRO conducting Phase II-IV trials, regulatory consulting, early-phase safety and Proof-of-Concept studies, and biophysical efficacy testing for pharmaceutical, cosmetics, and personal care sponsors globally as a wholly-owned subsidiary of Eurofins Scientific SE.
Ownership category
akta.pro rank

Bioskin industry classification

Industry
Product category
Contract Research Organization (Dermatology Clinical Trials)
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals

Keywords

  • Dermatology clinical trials
  • Clinical research organization
  • Regulatory consulting dermatology
  • Pharmaceutical trial services
  • Cosmetics clinical testing

Where Bioskin is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Bioskin business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Development Services: Fees for conducting Phase II-IV clinical trials for dermatological products including NCEs, new formulations with known actives, and generics. Services include safety testing, efficacy testing/Proof-of-Concept, multicenter multinational trials.
  2. Regulatory Consulting: Strategic and regulatory consulting services for dermatology and related products
  3. Research Center Dermatology Services: Specialized dermatology research center providing clinical study capabilities and infrastructure
  4. Data Operations and Medical Writing: Data management, statistics, and medical writing services supporting clinical trials

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Bioskin product offering

Product offering

Core offering

Eurofins bioskin is a full-service Contract Research Organization (CRO) specialized in dermatology, providing strategic and regulatory consulting, early-phase human safety and Proof-of-Concept studies, vasoconstrictor assays, and global Phase II-IV multicenter multinational trials for new chemical entities, new formulations with known actives, generics, and aesthetic dermatology products. Services are delivered for pharmaceutical companies, cosmetics, and personal care companies developing dermatological products, supported by a dedicated dermatology research center, clinical project management, monitoring, medical monitoring, data operations, quality management, and medical writing.

Product overview

Eurofins bioskin is a full-service CRO (Contract Research Organization) specialized in dermatology offering an integrated portfolio of services. The company provides strategic and regulatory consulting for dermatology and related products, early phase human safety and Proof-of-Concept studies, vasoconstrictor assays, and global Phase II-IV trials for NCEs, new formulations with known actives, and generics. The service portfolio spans Clinical Development (including Safety, Efficacy Testing, Multicenter Multinational Trials, Generics, International Partnering, Aesthetics, and Biophysical Measurement Methods), Research Center Dermatology, Clinical Project Management, Monitoring, Medical Monitoring, Data Operations (Data Management and Statistics), Quality Management, and Medical Writing. The services are designed to work together as an integrated offering for pharmaceutical and cosmetics companies conducting dermatology clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dermatologic Consulting and Regulatory
  • Clinical Development
  • Research Center Dermatology
  • Clinical Project Management
  • Monitoring
  • Medical Monitoring
  • Data Operations
  • Quality Management
  • Medical Writing
  • Vasoconstrictor Assays

Companies that use Bioskin

Customer profile

Segments2 records

Ideal customer profiles2 records

Bioskin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Bioskin partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Eurofins GroupcoreStrategic or Co-development PartnerBioskin operates as a subsidiary of Eurofins Group, a global leader in bioanalytics testing. This affiliation provides access to Eurofins' broader laboratory infrastructure, regulatory expertise, and international network while maintaining specialized focus on dermatological clinical research.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Bioskin competitors and assessment

Company assessment

Direct peers

  • Biorasi: Biorasi is a dermatology-focused CRO running clinical programs for skin and aesthetic indications. Like Bioskin it competes for the same niche sponsors seeking therapeutic-area depth over scale.
  • Proinnovera: Proinnovera is a German-based dermatology CRO offering clinical trial services for skin and aesthetic products. Geographically and therapeutically, it is one of Bioskin's closest competitors in Europe.
  • Novum Pharmaceutical Research Services: Novum is a US-based dermatology-specialized CRO with a similar Phase II–IV service profile. It competes head-to-head with Bioskin for North American and global dermatology sponsors.

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO with a broad dermatology practice. It competes with Bioskin on Phase III dermatology programs and uses its scale to bid down specialty CROs.
  • Parexel International: Parexel is a top-5 global CRO with active dermatology and aesthetics business. It is a frequent alternative when sponsors consolidate work with large generalist providers.
  • ICON plc: ICON is a major global CRO with therapeutic-area breadth including dermatology. It competes for the same Phase II–IV dermatology RFPs as Bioskin, especially in larger pivotal programs.
  • Medpace: Medpace is a mid-to-large global CRO with growing dermatology exposure. Its full-service model and therapeutic-area teams compete with Bioskin for sponsor mindshare in dermatology.
  • Syneos Health: Syneos Health is a global biopharma solutions organization offering CRO services including dermatology. It is a competitor for integrated clinical development work in skin indications.
  • Charles River Laboratories: Charles River is a global CRO/CDMO with a sizable clinical services business that touches dermatology sponsors. It competes on the broader Phase II–IV dermatology RFP set.

Emerging players

  • TFS International: TFS International is a mid-sized global CRO with growing dermatology and aesthetics work. It is a comparable-sized specialist expanding into the same niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Bioskin social profiles

Digital presence

Bioskin compliance and trust

Trust signal

Compliance1 record

Bioskin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioskin leadership team

Management profile

Number of profiles

Profiles2 records

Bioskin funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioskin M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioskin

What does Bioskin do?

Eurofins bioskin is a full-service Contract Research Organization (CRO) specialized in dermatology, providing strategic and regulatory consulting, early-phase human safety and Proof-of-Concept studies, vasoconstrictor assays, and global Phase II-IV multicenter multinational trials for new chemical entities, new formulations with known actives, generics, and aesthetic dermatology products. Services are delivered for pharmaceutical companies, cosmetics, and personal care companies developing dermatological products, supported by a dedicated dermatology research center, clinical project management, monitoring, medical monitoring, data operations, quality management, and medical writing.

Is Bioskin a public or private company?

Bioskin is a private company. It is classified as corporate owned and is currently operating.

When was Bioskin founded?

Bioskin was founded in 1992. It employs 51 to 100 people.

Where is Bioskin based?

Bioskin is headquartered in Hamburg, Germany, in the Europe region.

How does Bioskin make money?

Four revenue lines are on record. Clinical Development Services are the primary driver. The others are regulatory Consulting, research Center Dermatology Services and data Operations and Medical Writing.

Who are Bioskin's main competitors?

Direct peers on record are Biorasi, Proinnovera and Novum Pharmaceutical Research Services. Broad incumbents are IQVIA, Parexel International, ICON plc, Medpace, Syneos Health and Charles River Laboratories. TFS International is listed as an emerging player.

Does Bioskin have an API?

No public API is recorded for Bioskin.

What industry is Bioskin in?

Bioskin's product category is Contract Research Organization (Dermatology Clinical Trials). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales